Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

3.4K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
3.4K
Menopause01:28

Menopause

5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Infertility in Males01:23

Infertility in Males

665
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
665
Signs of Puberty01:27

Signs of Puberty

2.1K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate brachytherapy followed by secondary urethral adenocarcinoma: A case report.

Urology case reports·2026
Same author

Multidisciplinary management in Fournier's gangrene.

Current problems in surgery·2024
Same author

Editorial Comment on "Algorithmic Midline Approach to Perineal Urethrostomy is Associated With Long-term Success and High Patient Satisfaction".

Urology·2024
Same author

Early Post-Operative Events After Urethroplasty in Obese Patients: A Multi-Institutional Retrospective Series.

Urology·2024
Same author

Current devices, outcomes, and pain management considerations in penile implant surgery: an updated review of the literature.

Asian journal of andrology·2024
Same author

Decreased Opioid Use and Equivalent Pain Score Outcomes After Robotic Urologic Surgery Using a Simplified Opioid Minimization Protocol: A Safety-Net Hospital Experience.

Urology practice·2023

Related Experiment Video

Updated: May 3, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K

Risks of testosterone replacement therapy in men.

E Charles Osterberg1, Aaron M Bernie1, Ranjith Ramasamy1

  • 1Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College, Starr 900, New York, NY, USA.

Indian Journal of Urology : IJU : Journal of the Urological Society of India
|February 6, 2014
PubMed
Summary
This summary is machine-generated.

Testosterone replacement therapy (TRT) offers benefits like improved libido, energy, bone health, and cardiac function for men with hypogonadism. However, TRT is not suitable for those with untreated prostate or breast cancer and requires monitoring for potential side effects.

Keywords:
Hypogonadismside-effectstestosterone replacement therapy

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.7K
Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

14.7K

Related Experiment Videos

Last Updated: May 3, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.7K
Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

14.7K

Area of Science:

  • Endocrinology
  • Men's Health
  • Pharmacology

Background:

  • Symptomatic hypogonadism affects numerous men, necessitating effective treatment options.
  • Testosterone replacement therapy (TRT) is a common therapeutic approach for this condition.
  • Understanding the benefits and risks of TRT is crucial for patient management.

Purpose of the Study:

  • To summarize the established benefits of testosterone replacement therapy.
  • To outline the contraindications for initiating TRT.
  • To highlight essential monitoring parameters for patients undergoing TRT.

Main Methods:

  • Literature review of documented benefits and side effects of TRT.
  • Analysis of contraindications based on existing clinical guidelines.
  • Identification of key monitoring parameters for TRT patients.

Main Results:

  • TRT demonstrates benefits including increased libido, energy, bone density, muscle mass, and cardioprotective effects.
  • TRT is contraindicated in individuals with untreated prostate or breast cancer.
  • Monitoring for side effects such as polycythemia, edema, and cardiac/hepatic dysfunction is recommended.

Conclusions:

  • Testosterone replacement therapy is a well-documented treatment for symptomatic hypogonadism with significant benefits.
  • Careful patient selection is essential, excluding those with specific cancers.
  • Regular monitoring is necessary to manage potential adverse effects of TRT.